Citation tools
"Investigation into MAO B-mediated formation of CC112273, a major circulating metabolite of ozanimod, in humans and preclinical species: Stereospecific oxidative deamination of (S)-enantiomer of indaneamine (RP101075) by MAO B." Drug Metabolism and Disposition
(2021):
DMD-AR-2021-000447.
Web. 19 April. 2024.